Search

everythinglearnresearchcommunity

for

Search:↓

Metreleptin treatment significantly improved metabolic health in a boy with congenital generalized lipodystrophy.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Tofacitinib may help regrow hair in alopecia areata patients.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

A girl with a rare skin condition improved after one month of treatment with acitretin.

Baricitinib and tofacitinib have different safety patterns in treating alopecia areata.

Metformin and liraglutide improved symptoms of HAIR-AN syndrome in a child.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

HDAC inhibitors help brain cells grow and improve brain function.

Acitretin helped improve hand mobility and skin condition in a patient.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Low-dose Ritlecitinib may help children with stubborn Alopecia Areata.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Oral retinoids are effective for various skin conditions but have side effects and should not be used during pregnancy.

GLP-1 agonists may increase the risk of hair loss.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.

Switching to generic tacrolimus was safe, effective, and saved money.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Tofacitinib may help treat Lichen Planopilaris, but more research is needed.